Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

▪ Background: Treatment-free remission (TFR) is a new treatment goal for patients with chronic myeloid leukemia in chronic phase (CML-CP) with a sustained deep molecular response (DMR) by treatment with tyrosine kinase inhibitors (TKI). Although several guidelines have proposed clinical factors for...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-11, Vol.138 (Supplement 1), p.1477-1477
Hauptverfasser:	Yoshida, Chikashi, Yamaguchi, Hiroki, Doki, Noriko, Murai, Kazunori, Iino, Masaki, Hatta, Yoshihiro, Onizuka, Makoto, Yokose, Norio, Fujimaki, Katsumichi, Hagihara, Masao, Oshikawa, Gaku, Murayama, Kayoko, Kumagai, Takashi, Kimura, Shinya, Muto, Hideharu, Usuki, Kensuke, Yokoyama, Kenji, Yamamoto, Koh, Aotsuka, Nobuyuki, Ishizawa, Kenichi, Takezako, Naoki, Miyagishima, Takuto, Ishida, Tadao, Shinagawa, Atsushi, Wakasa, Kentaro, Nakamaki, Tsuyoshi, Tomita, Naoto, Ozaki, Katsutoshi, Itoh, Takayoshi, Kowata, Shugo, Tajika, Kenji, Fujio, Takayuki, Onozawa, Masahiro, Yamamoto, Masahide, Kondo, Takeshi, Najima, Yuho, Iriyama, Noriyoshi, Tsutsumi, Ikuyo, Oba, Koji, Kojima, Hiroshi, Sakamaki, Hisashi, Inokuchi, Koiti
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!